≡

Multiplex Assay Kit for Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay)

NTS; NTS1; NmN-125; NN; Tail peptide Neuromedin N

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 92-101 97
EDTA plasma(n=5) 81-89 85
heparin plasma(n=5) 98-105 102

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 95-103% 86-94% 78-101% 89-101%
EDTA plasma(n=5) 91-98% 80-90% 90-98% 85-98%
heparin plasma(n=5) 91-99% 92-101% 84-91% 99-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:NT) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 50μL standard or sample to each well,
    add 10μL magnetic beads,and 50μL Detection Reagent A,incubate 60min at 37°C on shaker;
3. Wash plate on magnetic frame for three times;
4. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
5. Wash plate on magnetic frame for three times;
6. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Biomed Research International Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation pubmed:29082242
Molecular Neurobiology Inhibition of Peroxynitrite-induced mitophagy activation attenuates cerebral ischemia-reperfusion injury Pubmed:29307080
Disease Markers Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS
Digestive and Liver Disease Functional analysis of gut microbiota and immunoinflammation in children with autism spectrum disorders Pubmed: 31320306
Biomolecules Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds … Pubmed: 32823854
Biomed Research International Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats … Pubmed: 32626732
Nutrition, Metabolism and Cardiovascular Diseases Identification of U-shaped Curve Relation in Pro-neurotensin and Risk of Coronary Artery Disease (CAD) in Premature CAD Patients
Effect of dobutamine on intrinsic myocardial function and myocardial apoptosis in septic rats with myocardial dysfunction
ACTA PHARMACOLOGICA SINICA Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy 33785860
J Cell Mol Med Elabela gene therapy promotes angiogenesis after myocardial infarction 34291565
Medicina (Kaunas) Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients 34946293
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB203Ra01 Recombinant Neurotensin (NT) Positive Control; Immunogen; SDS-PAGE; WB.
CPB203Ra21 OVA Conjugated Neurotensin (NT) Immunogen; SDS-PAGE; WB.
CPB203Ra22 OVA Conjugated Neurotensin (NT) Immunogen; SDS-PAGE; WB.
PAB203Ra01 Polyclonal Antibody to Neurotensin (NT) WB; IHC; ICC; IP.
MAB203Ra21 Monoclonal Antibody to Neurotensin (NT) WB; IHC; ICC; IP.
CEB203Ra ELISA Kit for Neurotensin (NT) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB203Ra Multiplex Assay Kit for Neurotensin (NT) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB203Ra11 ELISA Kit DIY Materials for Neurotensin (NT) Main materials for "Do It (ELISA Kit) Yourself".